Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children

Mostrar otras versiones (1)

Emergent SARS-CoV-2 variants and waning humoral immunity in vaccinated individuals have resulted in increased infections and hospitalizations. Children are not spared from infection nor complications of COVID-19, and the recent recommendation for boosters in individuals ages 12 years or older calls...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Madeleine D., Boribong, Brittany P., Bartsch, Yannic C., Loiselle, Maggie, St. Denis, Kerri J., Sheehan, Maegan L., Chen, Jessica W., Davis, Jameson P., Lima, Rosiane, Edlow, Andrea G., Fasano, Alessio, Balazs, Alejandro B., Alter, Galit, Yonker, Lael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032590/
https://www.ncbi.nlm.nih.gov/pubmed/35455241
http://dx.doi.org/10.3390/vaccines10040492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032590/
https://www.ncbi.nlm.nih.gov/pubmed/35455241
http://dx.doi.org/10.3390/vaccines10040492

Ejemplares similares